Active Ingredient(s):Etanercept-ykro FDA Approved: * April 25, 2019 Pharm Company: *SAMSUNG BIOEPIS CO LTD Category:Arthritis
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor. It has U.S. Food and Drug Administration (FDA) approval to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Tumor necrosis factor alpha (TNFα) is the "master regulator" o...
* May have multiple approval dates, manufacturers, or labelers.